So, targeting early steps in metastasis is less likely to be effective, as they might have already occurred at the time of diagnosis. Later steps might not have occurred at the time of cancer ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...

As discussed in the beginning, in some cases lung cancer can spread to other parts of the body such as the brain, liver, and bones. While smoking poses the highest risk, long-term exposure to air ...

HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.

This research represents a significant breakthrough in understanding the interactions between the brain's immune system and ...

In this video, Xiuning Le, MD, PhD, discusses the greatest areas of unmet need in the treatment of EGFR-mutated lung cancer.